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hypertension in a child
Hiroshi Date, MD,a Yoshifumi Sano, MD,a Motoi Aoe, MD,a Hiromi Matsubara, MD,b Kengo Kusano, MD,b
Keiji Goto, MD,c Takeo Tedoriya, MD,d and Nobuyoshi Shimizu, MD,a Okayama, Japan
The use of living lung donors has saved the lives ofpatients who are too ill to wait on the list for cadavericdonors.1 In this procedure, two healthy donors are usu-ally selected.2 One donor provides the right lower lobe,
and the other provides the left lower lobe. These lobes are im-
planted in the recipient as the whole right and left lungs. However,
finding two healthy living donors is not easy. To our knowledge,
this is the first reported case of single-lobe transplantation for
primary pulmonary hypertension.
Clinical Summary
A 10-year-old boy had been well until 6 years old in 1998, when
symptoms of dyspnea occurred during exercise. Primary pulmo-
nary hypertension was diagnosed, and oxygen inhalation and var-
ious oral medications were initiated. In May 1999, when the
patient was 8 years old, clinical deterioration required continuous
intravenous infusion of prostacyclin. Despite high-dose prostacy-
clin therapy (90 ng  kg1  min1), the patient remained in New
York Heart Association functional class III and was unable to go
to school. Right heart catheterization revealed highly elevated
pulmonary arterial pressure and a reduced cardiac index (Table 1).
Preoperative chest radiography demonstrated marked cardiomeg-
aly (Figure 1, A). Two-dimensional echocardiography demon-
strated a dilated hypokinetic right ventricle in association with an
enlarged right atrium and pulmonary artery, with massive tricuspid
regurgitation. Left ventricular function was normal apart from
flattening of the interventricular septum (Figure 2, A).
The patient qualified as a candidate for lung transplantation and
was registered in the Japan Organ Transplantation Network on
April 10, 2001. However, the only realistic option for this patient
was to receive a living-donor lobar lung transplant, because ob-
taining cadaveric donors is extremely difficult in Japan. The only
available living donor for the boy was his mother. The surgical
options were discussed with the family, and they were willing to
proceed with living-donor single-lobe transplantation, with the
understanding that it was still an experimental procedure.
On May 14, 2001, the patient underwent living-donor single-
lobe transplantation with the right lower lobe from his 38-year-
old mother. Heights and weights were 122 cm and 19.6 kg for
the recipient and 158 cm and 52.0 kg for the mother. The patient
was placed in the supine position, and a right anterolateral
thoracotomy was made at the level of the fourth intercostal
space. The costal cartilage of the fourth rib was divided to allow
upward mobility of the fourth rib with application of the rib-
spreading retractor. The sternum was not divided. A right
pneumonectomy and a right lower lobe implantation were per-
formed under conditions of cardiopulmonary bypass. The pa-
tient was separated from cardiopulmonary bypass easily after a
total of 147 minutes. The initial oxygen tension was 132.9 mm
Hg with the patient breathing 80% oxygen, and the systolic
pulmonary artery pressure was 32.0 mm Hg after discontinua-
tion of cardiopulmonary bypass.
During the early postoperative period, the patient was treated
with various cardiovascular medications, such as intravenously
administered dopamine, dobutamine, prostaglandin E1, and phos-
phodiesterase III inhibitor and inhaled nitric oxide. Postoperative
immunosuppression was a triple-drug therapy consisting of cyclo-
sporine, azathioprine, and prednisone. The patient was extubated
on postoperative day 3 but required emergency reintubation on
postoperative day 6 because of left native lung edema of unknown
cause. A perfusion scan and pulmonary angiography failed to
demonstrate any evidence of pulmonary embolism. Transesopha-
geal echocardiography demonstrated that pulmonary venous flow
was well maintained bilaterally. The patient was completely
weaned from the respirator within 9 days, and his further course
was relatively uneventful. He was discharged from the hospital
free of symptoms and without supplementary oxygen on postop-
erative day 43.
The postoperative right heart catheterization at 2 months re-
vealed remarkable improvement in pulmonary hemodynamics (Ta-
ble 1). Results of arterial blood gas and pulmonary function tests
were excellent. A differential ventilation/perfusion scan, per-
formed at 2 months after the operation, demonstrated 83.1% per-
fusion to the right lung (compared with 61.8% before the opera-
tion). Chest radiography demonstrated well-expanded grafts
without cardiomegaly (Figure 1, B). Echocardiographic changes
included decreases in right atrial and ventricular diameters, round
left ventricular shape, and minimum tricuspid regurgitation (Figure
2, B). The beneficial effects of this single-lobe transplantation were
maintained through a 6-month follow-up period (Table 1). Six
months after the operation, the patient has returned to normal
school life and is able to carry out daily activities.
Discussion
Living-donor lobar lung transplantation was introduced by Starnes
and colleagues1 for patients who were thought to be in too critical
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a condition to wait for a cadaveric lung transplantation. A single
donor was used in the beginning, and successful living-donor
single-lobe transplantation was reported for a 12-year-old girl with
bronchopulmonary dysplasia3 and an 11-year-old girl with pulmo-
nary fibrosis after bone marrow transplantation.4 However, a
4-year-old child with Eisenmenger syndrome died of massive
pulmonary edema related to inadequate microvasculature in the
allograft with the persistence of pulmonary hypertension.3 Because
of this, Starnes and coworkers1 developed bilateral living-donor
lobar lung transplantation, in which two healthy donors donate
their right or left lower lobes.
In Japan the number of available cadaveric donors is quite
limited (10 cases/y), and furthermore brain death is accepted
only for those older than 15 years old. It was therefore clear that
the only realistic option for this boy was to receive a living-donor
lobar lung transplant. Currently our institutional review board
protocol at Okayama University School of Medicine states that a
spouse or a relative within the second degree are the only donors
that can be used for living-donor lobar lung transplantation. The
patient’s father was not considered a suitable donor because of
blood type incompatibility, leaving his mother as the only suitable
donor.
The mother’s forced vital capacity was 3350 mL. Because the
right lower lobe comprises 5 of the 19 lung segments, the forced
vital capacity of the graft was estimated to be 882 mL (3350 mL
5/19 ), or 52.3% of the recipient’s predicted forced vital capacity
Figure 1. Chest radiography of 10-year-old boy with primary pulmonary hypertension. A, Before transplantation,
marked cardiomegaly is present. B, Two months after receiving right single-lobe transplantation with his mother’s
right lower lobe, well-expanded lobe fills right chest cavity without cardiomegaly, leaving no detectable dead
space.
TABLE 1. Assessment of lung and cardiac function
Pretransplant
Posttransplant
2 mo 6 mo
PAP (mm Hg) 85/40 (59) 37/15 (27) 38/12 (22)
PCWP (mm Hg) 8 8 10
CVP (mm Hg) 9 2 3
CI (L  min1  m2) 2.7 5.0 4.3
PaO2 (mm Hg) 139.1 (O2 2 L/min) 94.0 (room air) 99.7 (room air)
PaCO2 (mm Hg) 38.2 38.1 30.7
VC (mL) 1170 1350 1410
%VC (%) 69.6 78.9 78.3
FEV1 (mL) 1.02 1.16 1.03
Ventilation
Right (%) 61.1 62.2 56.9
Left (%) 38.9 37.8 43.1
Perfusion
Right (%) 61.8 83.1 81.6
Left (%) 38.2 16.9 18.4
PAP, Pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; CI, cardiac index; PaO2 , arterial oxygen
tension; PaCO2, arterial carbon dioxide tension; VC, vital capacity; FEV1, forced expiratory volume in 1 second.
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(1685 mL). We considered 52.3% to be within an acceptable
range, because single-lung transplantation had previously been
performed successfully for patients with primary pulmonary hy-
pertension.5
There were obvious concerns regarding whether pulmonary
edema would develop in the transplanted single lobe because a
preponderance of pulmonary flow would be directed to the trans-
planted single lobe as a result of high pulmonary vascular resis-
tance in the remaining native lung. Pulmonary arterial pressure
became nearly normal immediately after transplantation, and pul-
monary edema did not occur in the transplanted lobe even though
it received more than 80% of the cardiac output.
These findings validated the functional capacity of a single lobe
to handle the cardiac output of a recipient with primary pulmonary
hypertension when the size matching is adequate. However, long-
term durability of these hemodynamics as the boy grows remains
a major unresolved issue.
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Figure 2. Echocardiographic images before and after single-lobe transplantation. A, Before transplantation, dilated
hypokinetic right ventricle (RV) and D-shaped left ventricle (LV) are demonstrated. B, Two months after transplan-
tation, note marked decrease in right ventricular diameter and round left ventricle.
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